These changes contributed to reducing hepatic steatosis and improving insulin sensitivity in this sex, as evidenced by the lower Srebp1c expression, the greater AKT activation, and the higher insulin-induced suppression of PEPCK activity observed compared to females. The gene discussed is AKT1; the disease is Hepatic steatosis.